Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Headache

Showing results (791-800 of 4,992) with videos related to

Pageof 500
Sort By:
Headache|May 4, 2023
Characteristics of patients who visited emergency departments for headache in South Korea: A descriptive cross-sectional studySong Yi Park, Jiyoung Kim
Headache|April 28, 2023
Learning headache triggers through experience: A laboratory studyDana P Turner, Timothy T Houle
Headache|May 15, 2023
Efficacy of dual enkephalinase inhibition in a preclinical migraine model is mediated by activation of peripheral delta opioid receptorsHao-Ruei Mei, Ya-Yu Hu, Soneet Kapadia, et al.
Headache|May 28, 2014
A flexible format interdisciplinary treatment and rehabilitation program for chronic daily headache: patient clinical features, resource utilization and outcomesPamela M Barton, Geoffrey R Schultz, John F Jarrell, et al.
Headache|January 10, 2014
Clinical trials update. 2013: year in reviewStephen J Peroutka
Headache|January 10, 2014
The multitarget drug approach in migraine treatment: the new challenge to conquerAbimael González-Hernández, Miguel Condés-Lara
Headache|June 25, 2014
Headache and arachnoid cystsJacob Cherian, Ashwin Viswanathan, Randolph W Evans
Headache|March 29, 2021
Impact of abuse on migraine-related sensory hypersensitivity symptoms: Results from the American Registry for Migraine ResearchMeesha Trivedi, Gina Dumkrieger, Catherine D Chong, et al.
Headache|April 2, 2021
Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes StudyDawn C Buse, Cynthia E Armand, Larry Charleston, et al.
Headache|August 18, 2020
Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for MigraineGary Berman, Robert Croop, David Kudrow, et al.
Pageof 500

Showing results (791-800 of 4,992) with videos related to

Sort By:
Pageof 500
Headache|May 4, 2023
Characteristics of patients who visited emergency departments for headache in South Korea: A descriptive cross-sectional studySong Yi Park, Jiyoung Kim
Headache|April 28, 2023
Learning headache triggers through experience: A laboratory studyDana P Turner, Timothy T Houle
Headache|May 15, 2023
Efficacy of dual enkephalinase inhibition in a preclinical migraine model is mediated by activation of peripheral delta opioid receptorsHao-Ruei Mei, Ya-Yu Hu, Soneet Kapadia, et al.
Headache|May 28, 2014
A flexible format interdisciplinary treatment and rehabilitation program for chronic daily headache: patient clinical features, resource utilization and outcomesPamela M Barton, Geoffrey R Schultz, John F Jarrell, et al.
Headache|January 10, 2014
Clinical trials update. 2013: year in reviewStephen J Peroutka
Headache|January 10, 2014
The multitarget drug approach in migraine treatment: the new challenge to conquerAbimael González-Hernández, Miguel Condés-Lara
Headache|June 25, 2014
Headache and arachnoid cystsJacob Cherian, Ashwin Viswanathan, Randolph W Evans
Headache|March 29, 2021
Impact of abuse on migraine-related sensory hypersensitivity symptoms: Results from the American Registry for Migraine ResearchMeesha Trivedi, Gina Dumkrieger, Catherine D Chong, et al.
Headache|April 2, 2021
Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes StudyDawn C Buse, Cynthia E Armand, Larry Charleston, et al.
Headache|August 18, 2020
Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for MigraineGary Berman, Robert Croop, David Kudrow, et al.
Pageof 500